<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns="http://purl.org/rss/1.0/"><channel rdf:about="http://www.aurisnasuslarynx.com/?rss=yes"><title>Auris Nasus Larynx</title><description>Auris Nasus Larynx RSS feed: Current Issue.    The international journal  Auris Nasus Larynx  provides the opportunity for rapid, carefully reviewed publications concerning the 
fundamental and clinical aspects of otorhinolaryngology and related fields. This includes otology, neurotology, bronchoesophagology, 
laryngology, rhinology, allergology, head and neck medicine and oncologic surgery, maxillofacial and plastic surgery, audiology, speech 
science. 
 Original papers, short communications and original case reports can be submitted. Reviews on recent developments are invited 
regularly and Letters to the Editor commenting on papers or any aspect of  Auris Nasus Larynx  are welcomed. 
 Founded in 1973 
and previously published by the Society for Promotion of International Otorhinolaryngology, the journal is now the official English-language 
journal of the Oto-Rhino-Laryngological Society of Japan, Inc. The aim of its new international Editorial Board is to make   Auris 
Nasus Larynx  an international forum for high quality research and clinical sciences.   </description><link>http://www.aurisnasuslarynx.com/?rss=yes</link><dc:publisher>Elsevier Inc.</dc:publisher><dc:language>en</dc:language><dc:rights> © 2012 Published by Elsevier Inc. All rights reserved. </dc:rights><prism:publicationName>Auris Nasus Larynx</prism:publicationName><prism:issn>0385-8146</prism:issn><prism:volume>39</prism:volume><prism:number>2</prism:number><prism:publicationDate>April 2012</prism:publicationDate><prism:copyright> © 2012 Published by Elsevier Inc. All rights reserved. </prism:copyright><prism:rightsAgent>healthpermissions@elsevier.com</prism:rightsAgent><items><rdf:Seq><rdf:li rdf:resource="http://www.aurisnasuslarynx.com/article/PIIS0385814612000478/abstract?rss=yes"/><rdf:li rdf:resource="http://www.aurisnasuslarynx.com/article/PIIS0385814611001386/abstract?rss=yes"/><rdf:li rdf:resource="http://www.aurisnasuslarynx.com/article/PIIS0385814611001271/abstract?rss=yes"/><rdf:li rdf:resource="http://www.aurisnasuslarynx.com/article/PIIS0385814611001325/abstract?rss=yes"/><rdf:li rdf:resource="http://www.aurisnasuslarynx.com/article/PIIS0385814611001350/abstract?rss=yes"/><rdf:li rdf:resource="http://www.aurisnasuslarynx.com/article/PIIS0385814611001374/abstract?rss=yes"/><rdf:li rdf:resource="http://www.aurisnasuslarynx.com/article/PIIS0385814611001520/abstract?rss=yes"/><rdf:li rdf:resource="http://www.aurisnasuslarynx.com/article/PIIS0385814611001337/abstract?rss=yes"/><rdf:li rdf:resource="http://www.aurisnasuslarynx.com/article/PIIS0385814611002136/abstract?rss=yes"/><rdf:li rdf:resource="http://www.aurisnasuslarynx.com/article/PIIS0385814611001313/abstract?rss=yes"/><rdf:li rdf:resource="http://www.aurisnasuslarynx.com/article/PIIS038581461100215X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.aurisnasuslarynx.com/article/PIIS0385814611002008/abstract?rss=yes"/><rdf:li rdf:resource="http://www.aurisnasuslarynx.com/article/PIIS0385814611002161/abstract?rss=yes"/><rdf:li rdf:resource="http://www.aurisnasuslarynx.com/article/PIIS038581461100143X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.aurisnasuslarynx.com/article/PIIS0385814611001295/abstract?rss=yes"/><rdf:li rdf:resource="http://www.aurisnasuslarynx.com/article/PIIS0385814611001301/abstract?rss=yes"/><rdf:li rdf:resource="http://www.aurisnasuslarynx.com/article/PIIS0385814611001453/abstract?rss=yes"/><rdf:li rdf:resource="http://www.aurisnasuslarynx.com/article/PIIS0385814611001349/abstract?rss=yes"/><rdf:li rdf:resource="http://www.aurisnasuslarynx.com/article/PIIS0385814611001362/abstract?rss=yes"/><rdf:li rdf:resource="http://www.aurisnasuslarynx.com/article/PIIS0385814611001428/abstract?rss=yes"/><rdf:li rdf:resource="http://www.aurisnasuslarynx.com/article/PIIS0385814611001404/abstract?rss=yes"/><rdf:li rdf:resource="http://www.aurisnasuslarynx.com/article/PIIS0385814611001416/abstract?rss=yes"/><rdf:li rdf:resource="http://www.aurisnasuslarynx.com/article/PIIS0385814611002045/abstract?rss=yes"/><rdf:li rdf:resource="http://www.aurisnasuslarynx.com/article/PIIS0385814611001787/abstract?rss=yes"/></rdf:Seq></items></channel><item rdf:about="http://www.aurisnasuslarynx.com/article/PIIS0385814612000478/abstract?rss=yes"><title>Editorial Board</title><link>http://www.aurisnasuslarynx.com/article/PIIS0385814612000478/abstract?rss=yes</link><description></description><dc:title>Editorial Board</dc:title><dc:creator></dc:creator><dc:identifier>10.1016/S0385-8146(12)00047-8</dc:identifier><dc:source>Auris Nasus Larynx 39, 2 (2012)</dc:source><dc:date>2012-04-01</dc:date><prism:publicationName>Auris Nasus Larynx</prism:publicationName><prism:publicationDate>2012-04-01</prism:publicationDate><prism:volume>39</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0385-8146(12)X0002-6</prism:issueIdentifier><prism:section></prism:section><prism:startingPage>ii</prism:startingPage><prism:endingPage>ii</prism:endingPage></item><item rdf:about="http://www.aurisnasuslarynx.com/article/PIIS0385814611001386/abstract?rss=yes"><title>Current understanding and management of nasopharyngeal carcinoma</title><link>http://www.aurisnasuslarynx.com/article/PIIS0385814611001386/abstract?rss=yes</link><description>Abstract: Nasopharyngeal carcinoma (NPC) is a kind of rare head and neck cancer in Japan. However, NPC has some unique features. It is one of the most popular cancers in southern China, Southeast Asia, the Arctic, and the middle East/north Africa. This distinctive racial, ethnical, and geographic predisposition to NPC implies that both genetic susceptibility and environmental factors contribute to the development of this tumor. NPC is an Epstein-Barr virus – associated tumor. Consistent elevation of EBV antibody titers is a well-established risk factor of development of NPC. Not only pathophysiological relationship, but also molecular mechanism of EBV-mediated carcinogenesis has been enthusiastically investigated. LMP1, an EBV primary oncogene, upregulates each step of metastasis, and contribute to highly metastatic feature of NPC. A tumor suppressor gene p53 is mostly intact and overexpressed in NPC whereas expression of p16, a cyclin-dependent kinase inhibitory protein, is downregulated in 2/3 of NPC. Intention modulated radiotherapy (IMRT) is now getting prevalent for the treatment of NPC because of complicated structure and location of nasopharynx. A good therapeutic result can be achieved by distributing a high dose to the tumor while keeping down normal tissue complications by reducing radiation dose to normal tissues. Chemotherapy is important to control distant metastasis of chemoradiosensitive NPC, and thus, should play an important role. However, most effective combination of anti-tumor drugs, protocol of chemoradiotherapy has not well-established. Finally, molecular targeting therapy, including targeting EBV gene product, has been developing and on the way to the clinical use.</description><dc:title>Current understanding and management of nasopharyngeal carcinoma</dc:title><dc:creator>Tomokazu Yoshizaki, Makoto Ito, Shigekyuki Murono, Naohiro Wakisaka, Satoru Kondo, Kazuhira Endo</dc:creator><dc:identifier>10.1016/j.anl.2011.02.012</dc:identifier><dc:source>Auris Nasus Larynx 39, 2 (2012)</dc:source><dc:date>2012-04-01</dc:date><prism:publicationName>Auris Nasus Larynx</prism:publicationName><prism:publicationDate>2012-04-01</prism:publicationDate><prism:volume>39</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0385-8146(12)X0002-6</prism:issueIdentifier><prism:section>Review</prism:section><prism:startingPage>137</prism:startingPage><prism:endingPage>144</prism:endingPage></item><item rdf:about="http://www.aurisnasuslarynx.com/article/PIIS0385814611001271/abstract?rss=yes"><title>Evaluation of the effect of methylprednisolone and N-acetylcystein on anastomotic degeneration and regeneraton of the facial nerve</title><link>http://www.aurisnasuslarynx.com/article/PIIS0385814611001271/abstract?rss=yes</link><description>Abstract: Objectives: This study was aimed to determine the effects of methylprednisolone and N-acetylcystein on nerve healing in facial nerve anastomosis.Methods: Thirty rabbits were randomly divided into 3 groups: Group I: control group received no medication; Group II: 50mg/kg/day N-acetylcystein administered group; Group III, 1mg/kg/day Methylprednisolone administered group. All rabbits underwent the same standard surgical procedure. A 1mm segment was resected from the facial nerve and the free ends were anastomosed. The drugs were administered for two months twice a day. At the end of the second month, the anastomosed regions were dissected and examined under electron and light microscopy.Results: Best nerve regeneration was observed in the N-acetylcystein and the control groups, respectively, whereas the weakest regeneration was determined in the methylprednisolone group. In the N-acetylcystein group, due to Schwann cell and glial cell proliferation, the increased regeneration rate was significantly higher compared to that of the methylprednisolone group. In the methylprednisolone group, no significant regeneration was observed despite the presence of degenerative signs of significant axonal withdrawal and an increase in the number of myelin debris.Conclusion: In the present study, we demonstrated that methylprednisolone had no beneficial effect in nerve regeneration after facial nerve anastomosis. It further caused increased degeneration. On the contrary, N-acetylcystein administration significantly increased the extent of regeneration, whereas it decreased the extent of degeneration compared to the control and the methylprednisolone groups.</description><dc:title>Evaluation of the effect of methylprednisolone and N-acetylcystein on anastomotic degeneration and regeneraton of the facial nerve</dc:title><dc:creator>Turgut Karlidag, Mucahit Yildiz, Sinasi Yalcin, Neriman Colakoglu, Irfan Kaygusuz, Emrah Sapmaz</dc:creator><dc:identifier>10.1016/j.anl.2011.03.004</dc:identifier><dc:source>Auris Nasus Larynx 39, 2 (2012)</dc:source><dc:date>2012-04-01</dc:date><prism:publicationName>Auris Nasus Larynx</prism:publicationName><prism:publicationDate>2012-04-01</prism:publicationDate><prism:volume>39</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0385-8146(12)X0002-6</prism:issueIdentifier><prism:section>Otology/Neurotology</prism:section><prism:startingPage>145</prism:startingPage><prism:endingPage>150</prism:endingPage></item><item rdf:about="http://www.aurisnasuslarynx.com/article/PIIS0385814611001325/abstract?rss=yes"><title>Patterns of intracranial hemorrhage in petrous temporal bone fracture</title><link>http://www.aurisnasuslarynx.com/article/PIIS0385814611001325/abstract?rss=yes</link><description>Abstract: Objective: To study the relationship pattern of intracranial hemorrhage in cases of traumatic petrous temporal bone fracture.Methods: All head injury cases admitted to the Emergency Department, Hospital Tengku Ampuan Afzan, Pahang, Malaysia in 2008 were assessed. Computerized tomography (CT) scan of the skull base was performed in indicated cases. Patients with a petrous temporal bone fracture were included in the study. Subsequent magnetic resonance imaging (MRI) was performed. Intracranial hemorrhages incidence, management and outcome were recorded.Results: From 1421 cases of head injury, 49(3.4%) patients were diagnosed to have a petrous bone fracture from the CT scan. Only 46 cases underwent MRI scan and were included in this study. Of these, 36(78.3%) cases had associated intracranial hemorrhages (p&lt;0.01). Intracranial hemorrhage was associated with the longitudinal types of petrous fracture (p&lt;0.05). Subdural hematoma was the most prevalent type of bleed (55.6%). There was no association between the types of intracranial bleeding (extradural, subdural, subarachnoid or intracerebral hemorrhage) and the types of petrous bone fracture (longitudinal, oblique or transverse). The mortality rate was 17.4%. The mortality cases were associated with the presence of other skull bone fractures (p&lt;0.05).Conclusions: Petrous fracture is significantly associated with intracranial hemorrhage. There was no association between the types of petrous fracture and the types of intracranial hemorrhages in our material.</description><dc:title>Patterns of intracranial hemorrhage in petrous temporal bone fracture</dc:title><dc:creator>Zamzil Amin Asha’ari, Raja Ahmad, Jamalludin Rahman, Rosnida Azura Yusof, Norie Kamarudin</dc:creator><dc:identifier>10.1016/j.anl.2011.02.010</dc:identifier><dc:source>Auris Nasus Larynx 39, 2 (2012)</dc:source><dc:date>2012-04-01</dc:date><prism:publicationName>Auris Nasus Larynx</prism:publicationName><prism:publicationDate>2012-04-01</prism:publicationDate><prism:volume>39</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0385-8146(12)X0002-6</prism:issueIdentifier><prism:section>Otology/Neurotology</prism:section><prism:startingPage>151</prism:startingPage><prism:endingPage>155</prism:endingPage></item><item rdf:about="http://www.aurisnasuslarynx.com/article/PIIS0385814611001350/abstract?rss=yes"><title>Hearing aids reduce overestimation in pre-fitting self-assessment</title><link>http://www.aurisnasuslarynx.com/article/PIIS0385814611001350/abstract?rss=yes</link><description>Abstract: Objective: When asking about hearing disability, the self-reported answers are not always equivalent to those of their family and neighbors. It is often experienced that family and neighbors indicate more severe hearing disability. Hearing difficulty itself may prevent hearing impaired subjects from understanding the degree of their own hearing disability. If their hearing impairment interferes with self-assessment of unaided hearing ability, it may change after a non-hearing aid user begins using hearing aids.Methods: Thirty-four adults who had almost no experience with using hearing aids participated in this study. Unaided hearing disability was assessed with visual analog scale (VAS) and ten 5-point category scales. The assessment was performed not only by the subject (pre-fitting self-assessment) but also by his/her family members, presumed to be understanding persons regarding the degree of his/her hearing disability (family-assessment). For evaluating the effect of amplification on self-assessment, re-assessment was performed more than three months later (post-fitting self-assessment). The overestimation in the pre-fitting self-assessment and the effect of amplification were investigated in comparison to the family- and post-fitting self-assessments.Results: The pre-fitting self-, family- and post-fitting self-VAS values for total hearing abilities were 50.5±15.6, 45.1±14.7 and 34.3±18.8, respectively. The pre-fitting self-VAS value was significantly higher than the family- and post-fitting self-VAS values (p&lt;0.05 and p&lt;0.01, respectively). For the 5-point category scale, the pre-fitting self-assessment was better than the family- and post-fitting self-assessments. Significant differences were observed in 1 and 2 situations, as compared with the family- and post-fitting self-assessments, respectively. These findings suggest the involvement of overestimation in pre-fitting self-assessment and its reduction after amplification with hearing aids. Although the pre-fitting self- and the family-VAS values were independent of the results of audiometric tests, the post-fitting self-VAS value was significantly related to the pure tone threshold and maximum speech recognition score (p&lt;0.05). Regarding the changes in self-VAS values after amplification, the higher the pre-fitting self-VAS value, the larger the decrease in the self-VAS value. Thus, amplification with hearing aids may reduce overestimation and change self-assessment to reflect the audiometric assessments.Conclusion: The pre-fitting self-assessment of hearing disability involves over estimation which is exacerbated by hearing difficulty. A high pre-fitting VAS value may reflect a large overestimation in hearing ability. This overestimation can be improved by the amplification with hearing aids.</description><dc:title>Hearing aids reduce overestimation in pre-fitting self-assessment</dc:title><dc:creator>Tadashi Nishimura, Yuka Uratani, Fumi Fukuda, Osamu Saito, Hiroshi Hosoi</dc:creator><dc:identifier>10.1016/j.anl.2011.02.011</dc:identifier><dc:source>Auris Nasus Larynx 39, 2 (2012)</dc:source><dc:date>2012-04-01</dc:date><prism:publicationName>Auris Nasus Larynx</prism:publicationName><prism:publicationDate>2012-04-01</prism:publicationDate><prism:volume>39</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0385-8146(12)X0002-6</prism:issueIdentifier><prism:section>Otology/Neurotology</prism:section><prism:startingPage>156</prism:startingPage><prism:endingPage>162</prism:endingPage></item><item rdf:about="http://www.aurisnasuslarynx.com/article/PIIS0385814611001374/abstract?rss=yes"><title>A cupulolith repositioning maneuver in the treatment of horizontal canal cupulolithiasis</title><link>http://www.aurisnasuslarynx.com/article/PIIS0385814611001374/abstract?rss=yes</link><description>Abstract: Objective: We evaluated outcomes and their significance of a new treatment method for horizontal canal cupulolithiasis that could be applied regardless of the side of the cupula where otoliths are attached.Methods: Consecutive 78 patients who showed persistent apogeotropic horizontal canal positional vertigo (horizontal canal cupulolithiasis) were enrolled, and they were treated with the new cupulolith repositioning maneuver.Results: Horizontal semicircular canal cupulolithiasis was alleviated in 97.4% of patients, after an average of 2.1 repetitions of the maneuver. Otoliths were suspected to be attached to the canal side of the cupula in 30 cases and the utricular side in 44 cases.Conclusion: The cupulolith repositioning maneuver is an effective method for treating horizontal canal cupulolithiasis. It may also provide an insight into the side of the cupula where otoliths are attached.</description><dc:title>A cupulolith repositioning maneuver in the treatment of horizontal canal cupulolithiasis</dc:title><dc:creator>Sung Huhn Kim, Sung-Woo Jo, Woon-Kyo Chung, Hyung Kwon Byeon, Won-Sang Lee</dc:creator><dc:identifier>10.1016/j.anl.2011.03.008</dc:identifier><dc:source>Auris Nasus Larynx 39, 2 (2012)</dc:source><dc:date>2012-04-01</dc:date><prism:publicationName>Auris Nasus Larynx</prism:publicationName><prism:publicationDate>2012-04-01</prism:publicationDate><prism:volume>39</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0385-8146(12)X0002-6</prism:issueIdentifier><prism:section>Otology/Neurotology</prism:section><prism:startingPage>163</prism:startingPage><prism:endingPage>168</prism:endingPage></item><item rdf:about="http://www.aurisnasuslarynx.com/article/PIIS0385814611001520/abstract?rss=yes"><title>Bacterial biofilms in chronic rhinosinusitis and their relationship with inflammation severity</title><link>http://www.aurisnasuslarynx.com/article/PIIS0385814611001520/abstract?rss=yes</link><description>Abstract: Aims: To identify the presence of bacterial biofilms on mucosal specimens from chronic rhinosinusitis (CRS) patients, and evaluate their relationship with severity of CRS.Methods: A prospective study of biofilms presence on 24 CRS patients compared with 12 controls was designed. The presence of biofilms was determined by scanning electron microscopy (SEM), and associations with the preoperative Lund–MacKay CT scores, Johansson endoscopic scores, and the history of ESS were assessed.Results: Biofilms were found in 13/24 CRS patients (54.2%) but in only 1/12 controls (8.3%; P&lt;0.01). CRS patients with and without biofilms had similar preoperative Lund–MacKay CT and Johansson endoscopic scores (P&gt;0.05). Patients with revision ESS showed a tendency of higher biofilms incidence (5/7, 71.4%) than those undergoing their first procedure (8/17, 47.1%), but did not reach a significant difference (P&gt;0.05).Conclusions: The higher incidence of biofilms in CRS patients suggests a role in the pathogenesis of CRS, but no correlation with severity of CRS.</description><dc:title>Bacterial biofilms in chronic rhinosinusitis and their relationship with inflammation severity</dc:title><dc:creator>Hai-Hong Chen, Xiang Liu, Chao Ni, Yin-Ping Lu, Gao-Yun Xiong, Yu-Yu Lu, Shen-Qing Wang</dc:creator><dc:identifier>10.1016/j.anl.2011.04.014</dc:identifier><dc:source>Auris Nasus Larynx 39, 2 (2012)</dc:source><dc:date>2012-04-01</dc:date><prism:publicationName>Auris Nasus Larynx</prism:publicationName><prism:publicationDate>2012-04-01</prism:publicationDate><prism:volume>39</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0385-8146(12)X0002-6</prism:issueIdentifier><prism:section>Rhinology</prism:section><prism:startingPage>169</prism:startingPage><prism:endingPage>174</prism:endingPage></item><item rdf:about="http://www.aurisnasuslarynx.com/article/PIIS0385814611001337/abstract?rss=yes"><title>Maxillary sinus hypoplasia with a patent ostiomeatal complex: A therapeutic dilemma</title><link>http://www.aurisnasuslarynx.com/article/PIIS0385814611001337/abstract?rss=yes</link><description>Abstract: Objective: Maxillary sinus hypoplasia (MSH) is a radiologically detectable abnormality of the maxillary sinus that can be associated with sinusitis. Symptomatic MSH patients with a patent ostiomeatal complex (MSHPO) constitute a particular therapeutic challenge.Methods: Ostiomeatal unit CT scans of 1293 patients with various sinonasal symptoms such as purulent discharge, postnasal drip, facial pain or headache were reviewed to determine the incidence, clinical symptoms and outcomes of MSHPO following medical treatment.Results: Seventy-five cases (5.8%) were found to have MSHPO. Excluding patients with nasal septal deviation and positive allergy test, 37 of those 75 patients (2.86% of the original cohort) had MSHPO as the only definable sinonasal abnormality. Radiographs showed all patients had antral mucosal thickening. Postnasal drip (43.2%) was the most common symptom, followed by nasal obstruction (40.5%), purulent rhinorrhea (32.4%), hyposmia or anosmia (32.4%), cough (21.6%) and headache (18.9%). Medical treatment consisted of clarithromycin and ebastine for all patients. Medical treatment resulted in complete symptom resolution in only 24.3% of patients.Conclusions: Primary MSHPO was present in approximately 3% of patients with sinonasal symptoms. The response rate to medical treatment was poor. MSHPO should be considered a differential diagnosis in patients presenting with non-specific sinonasal complaints.</description><dc:title>Maxillary sinus hypoplasia with a patent ostiomeatal complex: A therapeutic dilemma</dc:title><dc:creator>Yong Ju Jang, Ho Chan Kim, Ji Hyang Lee, Ji Heui Kim</dc:creator><dc:identifier>10.1016/j.anl.2011.04.004</dc:identifier><dc:source>Auris Nasus Larynx 39, 2 (2012)</dc:source><dc:date>2012-04-01</dc:date><prism:publicationName>Auris Nasus Larynx</prism:publicationName><prism:publicationDate>2012-04-01</prism:publicationDate><prism:volume>39</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0385-8146(12)X0002-6</prism:issueIdentifier><prism:section>Rhinology</prism:section><prism:startingPage>175</prism:startingPage><prism:endingPage>179</prism:endingPage></item><item rdf:about="http://www.aurisnasuslarynx.com/article/PIIS0385814611002136/abstract?rss=yes"><title>Effect of nasal mometasone furoate on the nasal and nasopharyngeal flora</title><link>http://www.aurisnasuslarynx.com/article/PIIS0385814611002136/abstract?rss=yes</link><description>Abstract: Objective: Mometasone furoate (MF) is one of the commonly used topical steroids, particularly for patients with allergic rhinitis. However, its effect on the colonization of bacteria that may cause superinfections by suppressing the local immunity is not known. Thus, we investigated the effect of MF use on the nasal and nasopharyngeal microbial flora.Materials and methods: Swab samples were taken from 35 patients who required MF monotherapy, just before and after one month of the treatment. Samples were maintained in Stuart's medium. Each swab was transferred to 1ml of a sterile saline solution, then into the standard agar. After incubation under 5% carbon dioxide at 37°C, colony number was detected per ml.Results: Colony counts of nasal or nasopharyngeal microbial flora did not show any statistically significant alteration with one month use of MF. However, an increase in potential pathogens as well as normal flora bacteria was determined in five of the patients and six patients acquired new nasopharyngeal potential pathogens, mostly Moraxella catarrhalis, Pseudomonas aeruginosa and Staphylococcus aureus, following the use of MF.Conclusion: The use of MF for one month did not statistically significantly change the nasal and nasopharyngeal flora. This study indicates that MF could be increase the colonization of the potential pathogens in some of the patients at the subclinical level particularly in the nasopharyngeal area.</description><dc:title>Effect of nasal mometasone furoate on the nasal and nasopharyngeal flora</dc:title><dc:creator>Fadlullah Aksoy, Hasan Demirhan, Gülüm İvgin Bayraktar, Yavuz Selim Yıldırım, Orhan Özturan, Nevriye Gönüllü, Burcu Sapmaz</dc:creator><dc:identifier>10.1016/j.anl.2011.05.008</dc:identifier><dc:source>Auris Nasus Larynx 39, 2 (2012)</dc:source><dc:date>2012-04-01</dc:date><prism:publicationName>Auris Nasus Larynx</prism:publicationName><prism:publicationDate>2012-04-01</prism:publicationDate><prism:volume>39</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0385-8146(12)X0002-6</prism:issueIdentifier><prism:section>Rhinology</prism:section><prism:startingPage>180</prism:startingPage><prism:endingPage>185</prism:endingPage></item><item rdf:about="http://www.aurisnasuslarynx.com/article/PIIS0385814611001313/abstract?rss=yes"><title>Reduced E-cadherin expression is associated with lymph node metastases in laryngeal squamous cell carcinoma</title><link>http://www.aurisnasuslarynx.com/article/PIIS0385814611001313/abstract?rss=yes</link><description>Abstract: Objective: To investigate the expression of E-cadherin and its relationship with clinicopathological parameters in laryngeal squamous cell carcinoma (LSCC).Methods: Sixty-four patients who had previously undergone complete resection of tumor for LSCC were studied retrospectively. The level of E-cadherin expression in tumor tissues and paired nontumor tissues were determined by immunohistochemistry.Results: The expression of E-cadherin in tumor tissues was significantly lower than nontumor tissues (P&lt;0.001). Reduced E-cadherin expression was significantly correlated with lymph node metastases (P&lt;0.001). Kaplan–Meier survival estimates showed a significant correlation between E-cadherin expression and patient survival rate (log-rank P&lt;0.05). Multivariate Cox proportional hazards model analysis confirmed that lymph node metastases (P=0.001) and tumor stage (P=0.013) were statistically significant, independent predictor of prognosis.Conclusion: Expression of E-cadherin is an independent predictor of lymph node metastases in LSCC. However, it does not appear to be a better prognostic predictor than other established markers in LSCC.</description><dc:title>Reduced E-cadherin expression is associated with lymph node metastases in laryngeal squamous cell carcinoma</dc:title><dc:creator>Jing-jia Li, Ge-hua Zhang, Xin-ming Yang, Shi-sheng Li, Xian Liu, Qin-tai Yang, Yuan Li, Jin Ye</dc:creator><dc:identifier>10.1016/j.anl.2011.04.003</dc:identifier><dc:source>Auris Nasus Larynx 39, 2 (2012)</dc:source><dc:date>2012-04-01</dc:date><prism:publicationName>Auris Nasus Larynx</prism:publicationName><prism:publicationDate>2012-04-01</prism:publicationDate><prism:volume>39</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0385-8146(12)X0002-6</prism:issueIdentifier><prism:section>Head and Neck</prism:section><prism:startingPage>186</prism:startingPage><prism:endingPage>192</prism:endingPage></item><item rdf:about="http://www.aurisnasuslarynx.com/article/PIIS038581461100215X/abstract?rss=yes"><title>Clinical impact of iodine staining for diagnosis of carcinoma in situ in the floor of mouth, and decision of adequate surgical margin</title><link>http://www.aurisnasuslarynx.com/article/PIIS038581461100215X/abstract?rss=yes</link><description>Abstract: Objective: The use of iodine staining has been recommended for the early detection of squamous cell carcinoma (SCC) in the upper aerodigestive tract. The purpose was to verify the effectiveness of iodine staining in detecting early squamous cell carcinoma in the floor of mouth.Methods: Between 1995 and 2005, otolaryngological examinations including the floor of mouth were performed for 2278 esophageal cancer patients as a screening program of high-risk patient group. Iodine staining was applied to a lightly reddish and/or white patch, and/or uneven lesions in the floor of the mouth. Forceps biopsy was performed for demarcated unstained or lightly stained lesions. Three patients with the tumors in the floor of mouth, which were diagnosed as more over T2 level just by visual examination, were excluded from this study. If SCC was found in the specimen, mucosal resection was performed with a safety margin of 2mm from the unstained or lightly stained lesion. The incidence, rate of carcinoma in situ, and prognosis of cancer of the floor of mouth (CFOM) were assessed.Results: Iodine staining was performed for 72 of 2278 patients (3.2%) according to the presence of suspicious reddish and/or whitish and/or uneven lesions. Of these, unstained or lightly stained areas after iodine staining were recognized in 47 patients and SCC was revealed in 28 of 47 patients. The diagnosis of other 19 patients included inflammatory mucosa (n=11), low grade dysplasia (n=6), and hyperkeratosis (n=2). Sensitivity and specificity of iodine staining for detecting SCC were 100% and 59.6%, respectively. Pathological diagnosis of the 28 patients included squamous cell carcinoma in situ (n=12), microinvasive squamous cell carcinoma (n=15) disease, and focal invasive squamous cell cancer (n=1). Twenty-four of 28 patients were treated with mucosal resection without mandible resection. The other 4 patients did not receive the treatment of CFOM due to concomitant far advanced esophageal cancer. In 24 patients undergoing mucosal resection, no patients developed local recurrence or metastasis to the cervical lymph nodes during an average of 74.2 months of follow-up period (from 7 to 156 months). The 5-year cause-specific survival of these patients was 100%.Conclusion: The use of iodine staining as a part of otolaryngological examinations may be beneficial for the early detection of CFOM, including carcinoma in situ and micro-invasive SCC. Moreover, it would be very useful to determine an adequate surgical margin for locally mucosal resection.</description><dc:title>Clinical impact of iodine staining for diagnosis of carcinoma in situ in the floor of mouth, and decision of adequate surgical margin</dc:title><dc:creator>Akihito Watanabe, Masanobu Taniguchi, Hitoshi Tsujie, Masao Hosokawa, Masahiro Fujita, Shigeyuki Sasaki</dc:creator><dc:identifier>10.1016/j.anl.2011.08.004</dc:identifier><dc:source>Auris Nasus Larynx 39, 2 (2012)</dc:source><dc:date>2012-04-01</dc:date><prism:publicationName>Auris Nasus Larynx</prism:publicationName><prism:publicationDate>2012-04-01</prism:publicationDate><prism:volume>39</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0385-8146(12)X0002-6</prism:issueIdentifier><prism:section>Head and Neck</prism:section><prism:startingPage>193</prism:startingPage><prism:endingPage>197</prism:endingPage></item><item rdf:about="http://www.aurisnasuslarynx.com/article/PIIS0385814611002008/abstract?rss=yes"><title>BRAFV600E mutation does not serve as a prognostic factor in Korean patients with papillary thyroid carcinoma</title><link>http://www.aurisnasuslarynx.com/article/PIIS0385814611002008/abstract?rss=yes</link><description>Abstract: Objectives: In recent years, BRAFV600E mutation has emerged as a promising prognostic marker for risk stratification of patients with papillary thyroid carcinoma (PTC). However, routine use of this marker has been questioned. In some parts of the world, particularly in Korea, the incidence of BRAFV600E mutation is too high to have true prognostic value. The relatively low number of tumors without BRAFV600E mutation would prejudice the efficient use of this marker in the Korean population.Methods: The study involved 107 patients with histologically confirmed conventional PTC after surgical management for thyroid cancer from April 2010 to December 2010. BRAFV600E mutation analysis was performed by polymerase chain reaction (PCR)-based amplification of DNA extracted from paraffin-embedded tumor specimens, and the relationship between BRAFV600E mutation and various prognostic factors was investigated.Results: BRAFV600E mutation was found to be present in 85 (79.4%) of 107 patients with conventional PTC. Analysis of the clinical characteristics as function of the presence or absence of BRAFV600E mutation revealed no differences between the BRAFV600E-positive and BRAFV600E-negative patients. Moreover, BRAFV600E mutation was not correlated with any of the prognostic factors including age ≥45 years, male gender, tumor size ≥1cm, multifocality, extra-thyroidal extension, concurrent Hashimoto's thyroiditis, and lymph node metastasis neither in the univariate nor in the multivariate analysis.Conclusions: BRAFV600E mutation does not significantly reflect tumor aggressiveness in Korean patients with conventional PTC. We consider that BRAFV600E mutation does not possess prognostic value in Korea, where it is prevalent, and where most of the PTC types are conventional.</description><dc:title>BRAFV600E mutation does not serve as a prognostic factor in Korean patients with papillary thyroid carcinoma</dc:title><dc:creator>Dongbin Ahn, June Sik Park, Jin Ho Sohn, Jae Hyug Kim, Sun-Kyun Park, An Na Seo, Ji Young Park</dc:creator><dc:identifier>10.1016/j.anl.2011.07.011</dc:identifier><dc:source>Auris Nasus Larynx 39, 2 (2012)</dc:source><dc:date>2012-04-01</dc:date><prism:publicationName>Auris Nasus Larynx</prism:publicationName><prism:publicationDate>2012-04-01</prism:publicationDate><prism:volume>39</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0385-8146(12)X0002-6</prism:issueIdentifier><prism:section>Head and Neck</prism:section><prism:startingPage>198</prism:startingPage><prism:endingPage>203</prism:endingPage></item><item rdf:about="http://www.aurisnasuslarynx.com/article/PIIS0385814611002161/abstract?rss=yes"><title>Acute supraglottitis in adults: What's the optimal airway intervention?</title><link>http://www.aurisnasuslarynx.com/article/PIIS0385814611002161/abstract?rss=yes</link><description>Abstract: Objectives: To validate the Friedman stage and define the proper timing for airway intervention in adult cases of acute supraglottitis, we evaluated the clinical courses and management of adult patients.Methods: 202 adult patients with acute supraglottitis were included in this study. The diagnosis of supraglottitis was established by flexible nasolaryngoscopic examination. Friedman stages were classified in each patient. In this study, the first three days of serial nasolaryngoscopic findings for each patient were evaluated.Results: All patients were treated successfully with only conservative methods. There were no significant differences between patients with Friedman stages I or II/III. Among the patients that had serial nasolaryngoscopic findings, only one patient presented with progressive swelling of the epiglottis, and there were no cases of persistent swelling.Conclusion: The airway intervention threshold should be raised from Friedman stages II–III. And, airway intervention should not be needed if patients are tolerant of their respiratory discomfort.</description><dc:title>Acute supraglottitis in adults: What's the optimal airway intervention?</dc:title><dc:creator>Hyun Ho Park, Jong Cheol Lee, Tae Hoon Lee, Joong Keun Kwon, Jung Kwon Nam</dc:creator><dc:identifier>10.1016/j.anl.2011.08.005</dc:identifier><dc:source>Auris Nasus Larynx 39, 2 (2012)</dc:source><dc:date>2012-04-01</dc:date><prism:publicationName>Auris Nasus Larynx</prism:publicationName><prism:publicationDate>2012-04-01</prism:publicationDate><prism:volume>39</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0385-8146(12)X0002-6</prism:issueIdentifier><prism:section>Laryngology</prism:section><prism:startingPage>204</prism:startingPage><prism:endingPage>207</prism:endingPage></item><item rdf:about="http://www.aurisnasuslarynx.com/article/PIIS038581461100143X/abstract?rss=yes"><title>A new device for delivering drugs into the inner ear: Otoendoscope with microcatheter</title><link>http://www.aurisnasuslarynx.com/article/PIIS038581461100143X/abstract?rss=yes</link><description>Abstract: Objectives: Intratympanic injection (ITI) of drugs into the inner ear is an attractive way to deliver therapy. However, if the round window membrane (RWM) cannot be visualized, adhesions need to be removed first before ITI can be performed. We developed and tested a novel otoendoscopy device that allows visualization of the RWM for the purpose of ITI.Methods: Our otoendoscope consists of a catheter channel for delivering drugs and a suction channel.Results: The novel otoendoscope for inner ear drug delivery has a fine needle with catheter, which can be used to remove or perforate round window niche (RWN) mucosal adhesions. The elliptical shape of the otoendoscope effectively captures the field in the light-guided area, resulting in bright images.Conclusions: Our otoendoscope can be used to apply drugs directly onto the surface of the RWM and to verify the correct placement of an inner ear drug delivery system, ensuring that it is safely in place.</description><dc:title>A new device for delivering drugs into the inner ear: Otoendoscope with microcatheter</dc:title><dc:creator>Sho Kanzaki, Hideyuki Saito, Yasuhiro Inoue, Kaoru Ogawa</dc:creator><dc:identifier>10.1016/j.anl.2011.04.006</dc:identifier><dc:source>Auris Nasus Larynx 39, 2 (2012)</dc:source><dc:date>2012-04-01</dc:date><prism:publicationName>Auris Nasus Larynx</prism:publicationName><prism:publicationDate>2012-04-01</prism:publicationDate><prism:volume>39</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0385-8146(12)X0002-6</prism:issueIdentifier><prism:section>Short communication</prism:section><prism:startingPage>208</prism:startingPage><prism:endingPage>211</prism:endingPage></item><item rdf:about="http://www.aurisnasuslarynx.com/article/PIIS0385814611001295/abstract?rss=yes"><title>Spontaneous regression of lung lesions after excision of the submandibular gland in a patient with chronic sclerosing sialadenitis</title><link>http://www.aurisnasuslarynx.com/article/PIIS0385814611001295/abstract?rss=yes</link><description>Abstract: Chronic sclerosing sialadenitis, which clinically resembles a salivary gland tumor, is considered a salivary gland lesion of the IgG4-related inflammatory disease. Corticosteroids are effective for the treatment of chronic sclerosing sialadenitis, but the natural clinical course of this disease is not fully understood. We report a 67-year-old man with chronic sclerosing sialadenitis who showed lung lesions, which spontaneously regressed without steroid therapy after excision of the submandibular gland. He presented with several weeks’ history of continuous swelling in the right submandibular region. Physical examination showed a hard swelling of the right submandibular gland; the cytological finding was Papanicolaou class III. A chest X-ray demonstrated bilateral infiltration of the right middle and left lower lobes. The right submandibular gland was excised under general anesthesia for definite diagnosis, and histopathological examination revealed an IgG4-positive plasmacytic infiltration accompanied by periductal fibrosis and interlobular sclerosis, consistent with chronic sclerosing sialadenitis. Five months after operation, the lung lesions regressed spontaneously.</description><dc:title>Spontaneous regression of lung lesions after excision of the submandibular gland in a patient with chronic sclerosing sialadenitis</dc:title><dc:creator>Nobuhiko Seki, Norikazu Yamazaki, Atsushi Kondo, Kazuaki Nomura, Tetsuo Himi</dc:creator><dc:identifier>10.1016/j.anl.2011.01.025</dc:identifier><dc:source>Auris Nasus Larynx 39, 2 (2012)</dc:source><dc:date>2012-04-01</dc:date><prism:publicationName>Auris Nasus Larynx</prism:publicationName><prism:publicationDate>2012-04-01</prism:publicationDate><prism:volume>39</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0385-8146(12)X0002-6</prism:issueIdentifier><prism:section>Case Reports</prism:section><prism:startingPage>212</prism:startingPage><prism:endingPage>215</prism:endingPage></item><item rdf:about="http://www.aurisnasuslarynx.com/article/PIIS0385814611001301/abstract?rss=yes"><title>3D analysis of spontaneous upbeat nystagmus in a patient with astrocytoma in cerebellum</title><link>http://www.aurisnasuslarynx.com/article/PIIS0385814611001301/abstract?rss=yes</link><description>Abstract: Aims: We report the case of a 58-year-old female patient who consulted our Department complaining of positional vertigo and showing spontaneous upbeat nystagmus (UBN) in darkness.Method: We analyzed her UBN three-dimensionally. The MRI scan revealed the astrocytoma in the left cerebellum involving the cerebellar vermis.Result: Three-dimensional analysis showed a spontaneous UBN rotating around the intra-aural axis in the pitch plane.Conclusion: Since the cerebellar vermis is known to plays an inhibitory role on the central vertical vestibule-ocular reflex (VOR), the present results suggest that the spontaneous UBN in darkness observed in this patient was induced by an imbalance of central vertical VOR tone.</description><dc:title>3D analysis of spontaneous upbeat nystagmus in a patient with astrocytoma in cerebellum</dc:title><dc:creator>Kayoko Higashi-Shingai, Takao Imai, Noriaki Takeda, Atsuhiko Uno, Suetaka Nishiike, Arata Horii, Tadashi Kitahara, Yuka Fuse, Misako Hashimoto, Osamu Senba, Tsuyoshi Suzuki, Toshiaki Fujita, Hideo Otsuki, Hidenori Inohara</dc:creator><dc:identifier>10.1016/j.anl.2011.03.005</dc:identifier><dc:source>Auris Nasus Larynx 39, 2 (2012)</dc:source><dc:date>2012-04-01</dc:date><prism:publicationName>Auris Nasus Larynx</prism:publicationName><prism:publicationDate>2012-04-01</prism:publicationDate><prism:volume>39</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0385-8146(12)X0002-6</prism:issueIdentifier><prism:section>Case Reports</prism:section><prism:startingPage>216</prism:startingPage><prism:endingPage>219</prism:endingPage></item><item rdf:about="http://www.aurisnasuslarynx.com/article/PIIS0385814611001453/abstract?rss=yes"><title>Endolaryngeal extension of thyroglossal duct cyst</title><link>http://www.aurisnasuslarynx.com/article/PIIS0385814611001453/abstract?rss=yes</link><description>Abstract: Thyroglossal duct cysts are the most common congenital neck masses that develop during childhood, The masses develop from remnants of thyroglossal ducts, and typically appear as midline neck masses. Endolaryngeal extension of thyroglossal duct cysts has been reported mostly as midline neck swelling. We observed a case of extension of the thyroglossal duct cyst to the supraglottic area without neck swelling. A 50-year-old man presented with a 1-month history of foreign-body sensation in the throat. Fiberscopic and radiologic findings were similar to those associated with a saccular cyst, but its proximity to the hyoid bone raised the possibility of thyroglossal duct cyst. Operation was performed via an external incision to completely remove the cyst. Postoperative fiberscopy revealed that the aryepiglottic fold swelling had disappeared. Diagnosis of thyroglossal duct cyst was confirmed on the basis of pathological findings. In cases in which it is difficult to remove the cyst from the hyoid membrane, the hyoid bone midline portion should be dissected. Thyroglossal duct cysts should be considered in cases with a submucosal tumor in the supraglottic region, and radiological examinations should be performed.</description><dc:title>Endolaryngeal extension of thyroglossal duct cyst</dc:title><dc:creator>Hideki Bando, Masaya Uchida, Sachie Matsumoto, Chihisa Ushijima, Kenji Dejima</dc:creator><dc:identifier>10.1016/j.anl.2011.04.008</dc:identifier><dc:source>Auris Nasus Larynx 39, 2 (2012)</dc:source><dc:date>2012-04-01</dc:date><prism:publicationName>Auris Nasus Larynx</prism:publicationName><prism:publicationDate>2012-04-01</prism:publicationDate><prism:volume>39</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0385-8146(12)X0002-6</prism:issueIdentifier><prism:section>Case Reports</prism:section><prism:startingPage>220</prism:startingPage><prism:endingPage>223</prism:endingPage></item><item rdf:about="http://www.aurisnasuslarynx.com/article/PIIS0385814611001349/abstract?rss=yes"><title>Successful treatment of rhino-orbital mucormycosis by a new combination therapy with liposomal amphotericin B and micafungin</title><link>http://www.aurisnasuslarynx.com/article/PIIS0385814611001349/abstract?rss=yes</link><description>Abstract: Mucormycosis is a rapidly progressive fungal infection that usually occurs in patients with diabetes mellitus or in immunocompromised patients. Sinus involvement is the most common clinical presentation and the rates of mortality increase with the orbital extension. The treatment of mucormycosis includes aggressive surgical debridement and systemic antifungal therapy. Early diagnosis and prompt initiation of effective antifungal drugs are essential for successful outcome. However, the role of orbital exenteration for the case of orbital involvement remains controversial, and the drugs effective against mucormycosis are limited. We present a successfully treated case with rhino-orbital mucormycosis caused by Rhizopus oryzae in a diabetic and dialysis patient. The early diagnosis, surgical debridement and a new combination therapy with liposomal amphotericin B and micafungin were effective. This new combination antifungal therapy will be useful for the treatment of mucormycosis.</description><dc:title>Successful treatment of rhino-orbital mucormycosis by a new combination therapy with liposomal amphotericin B and micafungin</dc:title><dc:creator>Takao Ogawa, Kumiko Takezawa, Ichiro Tojima, Masayuki Shibayama, Hideaki Kouzaki, Mitsuaki Ishida, Hidetoshi Okabe, Takeshi Shimizu</dc:creator><dc:identifier>10.1016/j.anl.2011.03.006</dc:identifier><dc:source>Auris Nasus Larynx 39, 2 (2012)</dc:source><dc:date>2012-04-01</dc:date><prism:publicationName>Auris Nasus Larynx</prism:publicationName><prism:publicationDate>2012-04-01</prism:publicationDate><prism:volume>39</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0385-8146(12)X0002-6</prism:issueIdentifier><prism:section>Case Reports</prism:section><prism:startingPage>224</prism:startingPage><prism:endingPage>228</prism:endingPage></item><item rdf:about="http://www.aurisnasuslarynx.com/article/PIIS0385814611001362/abstract?rss=yes"><title>Autoimmune recurrent facial palsy and bilateral sudden sensorineural hearing loss following Ramsay Hunt-like syndrome</title><link>http://www.aurisnasuslarynx.com/article/PIIS0385814611001362/abstract?rss=yes</link><description>Abstract: Objective: To describe the first published case of recurrent facial nerve palsy associated with bilateral sudden sensorineural hearing loss of autoimmune origin.Case report: A 33-year-old male presented with acute facial palsy on the left following a vesicular herpetic eruption in the external ear canal on the same side. Serologic measurements demonstrated an elevation of IgM antibodies against herpes simplex virus but not for varicella-zoster virus, confirming a Ramsay Hunt-like syndrome due to herpes simplex virus. The following four months, the patient exhibited other three episodes of facial palsy, well responded to steroid treatment. During the clinical course, a sudden sensorineural hearing loss was also diagnosed, initially on the left side and then on both sides. The autoimmune markers such as the antinuclear antibody and the anti-gangliosides antibodies (anti-GM1, anti-GQ1b) were found positive. Despite steroid treatment, hearing did not show any improvement, remaining moderate on the right and severe on the left.Conclusion: Recurrent facial nerve palsy and bilateral sudden sensorineural hearing loss could be the expression of autoimmune disturbances. The initial triggered factor could be the herpes simplex virus infection, such as a Ramsay Hunt-like syndrome.</description><dc:title>Autoimmune recurrent facial palsy and bilateral sudden sensorineural hearing loss following Ramsay Hunt-like syndrome</dc:title><dc:creator>George Psillas, Marianthi Arnaoutoglou, Trifonas Gatsios, Dimitris Rizos, Efrosini Koutsouraki, Victor Vital</dc:creator><dc:identifier>10.1016/j.anl.2011.03.007</dc:identifier><dc:source>Auris Nasus Larynx 39, 2 (2012)</dc:source><dc:date>2012-04-01</dc:date><prism:publicationName>Auris Nasus Larynx</prism:publicationName><prism:publicationDate>2012-04-01</prism:publicationDate><prism:volume>39</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0385-8146(12)X0002-6</prism:issueIdentifier><prism:section>Case Reports</prism:section><prism:startingPage>229</prism:startingPage><prism:endingPage>232</prism:endingPage></item><item rdf:about="http://www.aurisnasuslarynx.com/article/PIIS0385814611001428/abstract?rss=yes"><title>Lacrimal dacryostenosis with severe facial pain misdiagnosed as trigeminal neuralgia</title><link>http://www.aurisnasuslarynx.com/article/PIIS0385814611001428/abstract?rss=yes</link><description>Abstract: A 47-year-old woman developed intermittent shooting pain around the right side of the nose and eyes. A neurologist initially diagnosed trigeminal neuralgia, but carbamazepine did not improve the pain. Two months later, she presented with a pus-like eye discharge and was referred to us for further examination. Poor saline irrigation from the lacrimal puncta and computed tomography findings of a swollen lacrimal sac indicated a diagnosis of lacrimal dacryostenosis. At this point, the pain and dizziness as a side effect of carbamazepine had become intolerable. Endoscopic intranasal dacryocystorhinostomy confirmed stenosis of the nasolachrymal duct and a thickened lacrimal sac. The postoperative course was uneventful, and the facial pain disappeared. This experience suggests the importance of recognizing lacrimal dacryostenosis as a differential diagnosis of facial pain around the eyes and nose. We also recommend a review of an original diagnosis of trigeminal neuralgia if carbamazepine fails to relieve facial pain.</description><dc:title>Lacrimal dacryostenosis with severe facial pain misdiagnosed as trigeminal neuralgia</dc:title><dc:creator>Tohru Tanigawa, Hirokazu Sasaki, Masahiro Kaneda, Tessei Kuruma, Hiromi Ueda</dc:creator><dc:identifier>10.1016/j.anl.2011.04.005</dc:identifier><dc:source>Auris Nasus Larynx 39, 2 (2012)</dc:source><dc:date>2012-04-01</dc:date><prism:publicationName>Auris Nasus Larynx</prism:publicationName><prism:publicationDate>2012-04-01</prism:publicationDate><prism:volume>39</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0385-8146(12)X0002-6</prism:issueIdentifier><prism:section>Case Reports</prism:section><prism:startingPage>233</prism:startingPage><prism:endingPage>235</prism:endingPage></item><item rdf:about="http://www.aurisnasuslarynx.com/article/PIIS0385814611001404/abstract?rss=yes"><title>Reversible cochlear disorders with normal vestibular functions in three cases with Wegener's granulomatosis</title><link>http://www.aurisnasuslarynx.com/article/PIIS0385814611001404/abstract?rss=yes</link><description>Abstract: Patients with Wegener's granulomatosis (WG) often suffer from hearing loss, but its precise mechanisms have not been well understood. We experienced 3 WG cases whose initial symptoms were bilateral progressive mixed (both conductive and sensorineural) hearing loss, followed by systemic symptoms one year later. They were diagnosed as WG based on positive serology of anti-neutrophil cytoplasmic antibodies (ANCAs) and pathologic findings of affected lesions in addition to systemic symptoms. Although they were different in the type of ANCAs and systemic lesions, all showed considerably reversible cochlear disorders with normal vestibular functions. Moreover, their initial otologic manifestations shared same characteristic features, (1) thick ear drums with pulsatile serous intratympanic effusion, (2) poor speech discrimination ability, and (3) steroid-dependent changes of hearing levels (HLs). They exhibited no significant vestibular abnormalities in chair vestibule-ocular reflex (VOR) testing and cold air caloric tests even when they had severe hearing loss. On the basis of these results, we hypothesized that vasculitis of stria vascularis which generates endocochlear potential might cause these reversible cochlear-specific dysfunctions.</description><dc:title>Reversible cochlear disorders with normal vestibular functions in three cases with Wegener's granulomatosis</dc:title><dc:creator>Hiroshi Yamazaki, Keizo Fujiwara, Shogo Shinohara, Masahiro Kikuchi, Yuji Kanazawa, Risa Kurihara, Ippei Kishimoto, Yasushi Naito</dc:creator><dc:identifier>10.1016/j.anl.2011.03.010</dc:identifier><dc:source>Auris Nasus Larynx 39, 2 (2012)</dc:source><dc:date>2012-04-01</dc:date><prism:publicationName>Auris Nasus Larynx</prism:publicationName><prism:publicationDate>2012-04-01</prism:publicationDate><prism:volume>39</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0385-8146(12)X0002-6</prism:issueIdentifier><prism:section>Case Reports</prism:section><prism:startingPage>236</prism:startingPage><prism:endingPage>240</prism:endingPage></item><item rdf:about="http://www.aurisnasuslarynx.com/article/PIIS0385814611001416/abstract?rss=yes"><title>Actinomycosis presenting as a parotid tumor</title><link>http://www.aurisnasuslarynx.com/article/PIIS0385814611001416/abstract?rss=yes</link><description>Abstract: Actinomycosis of the parotid gland is a rare chronic infection and can present with a slow-growing mass mimicking a tumor. The authors report five cases of parotid actinomycosis. All patients presented as having enlarging masses at the parotid area for 2–6 months without a history of obvious dental infection, trauma, or immunocompromised condition. Retrograde bacterial spread from colonization in the oral cavity via Stensen's duct is the possible pathophysiology. The diagnosis was made histopathologically by fine needle aspiration biopsy (FNAB). Treatment consisted of 1.5 months of intravenous penicillin, followed by 4.5 months of oral penicillin, with excellent results.</description><dc:title>Actinomycosis presenting as a parotid tumor</dc:title><dc:creator>Pichit Sittitrai, Chonticha Srivanitchapoom, Thienchai Pattarasakulchai, Suree Lekawanavijit</dc:creator><dc:identifier>10.1016/j.anl.2011.03.011</dc:identifier><dc:source>Auris Nasus Larynx 39, 2 (2012)</dc:source><dc:date>2012-04-01</dc:date><prism:publicationName>Auris Nasus Larynx</prism:publicationName><prism:publicationDate>2012-04-01</prism:publicationDate><prism:volume>39</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0385-8146(12)X0002-6</prism:issueIdentifier><prism:section>Case Reports</prism:section><prism:startingPage>241</prism:startingPage><prism:endingPage>243</prism:endingPage></item><item rdf:about="http://www.aurisnasuslarynx.com/article/PIIS0385814611002045/abstract?rss=yes"><title>AICA syndrome with facial palsy following vertigo and acute sensorineural hearing loss</title><link>http://www.aurisnasuslarynx.com/article/PIIS0385814611002045/abstract?rss=yes</link><description>Abstract: We report a case of infarction of the anterior inferior cerebellar artery (AICA) with peripheral facial palsy following vertigo and acute sensorineural hearing loss. A 39-year-old female presented with vertigo and sudden hearing loss, tinnitus, and aural fullness of the right ear. An audiogram revealed a severe hearing loss at all tested frequencies in the right ear. Spontaneous nystagmus toward the left side was also observed. Otoneurological examinations showed sensorineural hearing loss of the right ear and horizontal and rotatory gaze nystagmus toward the left side, and a caloric reflex test demonstrated canal paresis. Initially, we diagnosed the patient for sudden deafness with vertigo. However, right peripheral facial palsy appeared 2 days later. An eye tracking test (ETT) and optokinetic pattern test (OKP) showed centralis abnormality. The patient's brain was examined by magnetic resonance imaging (MRI) and magnetic resonance angioglaphy (MRA) and showed an infarction localized in the pons and cerebellum. MRI and MRA revealed infarction of the right cerebellar hemisphere indicating occlusion of the AICA. Consequently, the patient was diagnosed with AICA syndrome but demonstrated regression following steroid and edaravone treatment. We suggest that performing MRI and MRA in the early stage of AICA syndrome is important for distinguishing cerebellar infarction resulting from vestibular disease.</description><dc:title>AICA syndrome with facial palsy following vertigo and acute sensorineural hearing loss</dc:title><dc:creator>Tomoko Ikegami-Takada, Masahiko Izumikawa, Tadashi Doi, Yohei Takada, Koichi Tomoda</dc:creator><dc:identifier>10.1016/j.anl.2011.07.015</dc:identifier><dc:source>Auris Nasus Larynx 39, 2 (2012)</dc:source><dc:date>2012-04-01</dc:date><prism:publicationName>Auris Nasus Larynx</prism:publicationName><prism:publicationDate>2012-04-01</prism:publicationDate><prism:volume>39</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0385-8146(12)X0002-6</prism:issueIdentifier><prism:section>Case Reports</prism:section><prism:startingPage>244</prism:startingPage><prism:endingPage>248</prism:endingPage></item><item rdf:about="http://www.aurisnasuslarynx.com/article/PIIS0385814611001787/abstract?rss=yes"><title>Surgical treatment for congenital absence of the oval window with facial nerve anomalies</title><link>http://www.aurisnasuslarynx.com/article/PIIS0385814611001787/abstract?rss=yes</link><description>Abstract: Three patients with a middle ear malformation characterized by the absence of the oval window and complicated by facial nerve anomalies were treated by surgery. Hearing ability of all the patients was improved.A variety of facial nerve anomalies were observed. Fenestration of the vestibule above the facial nerve was performed in the case of 2 of the 3 patients. In the other patient, fenestration of the scala vestibuli below the facial nerve was performed. In the case of all the 3 patients, hearing ability improved after the surgery and remained stable for a long time. Surgery for this disease has been considered difficult because of a high risk of complications. Because all the 3 patients showed excellent long-term surgical results, we suggest that fenestration of the inner ear should be considered one of the main options for the management and treatment of an absent oval window associated with facial nerve anomalies.</description><dc:title>Surgical treatment for congenital absence of the oval window with facial nerve anomalies</dc:title><dc:creator>Jun Hasegawa, Tetsuaki Kawase, Hiroshi Hidaka, Takeshi Oshima, Toshimitsu Kobayashi</dc:creator><dc:identifier>10.1016/j.anl.2011.04.016</dc:identifier><dc:source>Auris Nasus Larynx 39, 2 (2012)</dc:source><dc:date>2012-04-01</dc:date><prism:publicationName>Auris Nasus Larynx</prism:publicationName><prism:publicationDate>2012-04-01</prism:publicationDate><prism:volume>39</prism:volume><prism:number>2</prism:number><prism:issueIdentifier>S0385-8146(12)X0002-6</prism:issueIdentifier><prism:section>Case Reports</prism:section><prism:startingPage>249</prism:startingPage><prism:endingPage>255</prism:endingPage></item></rdf:RDF>
